Advisory Services Network LLC Has $1.12 Million Position in Kenvue Inc. (NYSE:KVUE)

Advisory Services Network LLC lifted its holdings in Kenvue Inc. (NYSE:KVUE) by 2.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,281 shares of the company’s stock after buying an additional 1,469 shares during the period. Advisory Services Network LLC’s holdings in Kenvue were worth $1,116,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Bard Financial Services Inc. grew its position in Kenvue by 5.7% during the third quarter. Bard Financial Services Inc. now owns 106,790 shares of the company’s stock valued at $2,470,000 after purchasing an additional 5,750 shares in the last quarter. Boyar Asset Management Inc. boosted its stake in shares of Kenvue by 7.2% during the 3rd quarter. Boyar Asset Management Inc. now owns 29,171 shares of the company’s stock valued at $675,000 after buying an additional 1,948 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Kenvue during the 3rd quarter valued at $1,057,000. Tidal Investments LLC increased its stake in shares of Kenvue by 9.9% in the third quarter. Tidal Investments LLC now owns 131,128 shares of the company’s stock worth $3,033,000 after acquiring an additional 11,849 shares during the last quarter. Finally, Oddo BHF Asset Management Sas purchased a new stake in shares of Kenvue during the third quarter worth $1,570,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Citigroup lowered their target price on Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 15th. Barclays boosted their price target on Kenvue from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Thursday, March 27th. UBS Group cut their price objective on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. Royal Bank of Canada reissued a “sector perform” rating and issued a $24.00 target price on shares of Kenvue in a research report on Monday, February 3rd. Finally, Redburn Atlantic assumed coverage on shares of Kenvue in a report on Thursday. They set a “neutral” rating and a $23.50 price target on the stock. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $24.42.

Kenvue Stock Up 1.1 %

Kenvue stock opened at $22.10 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The firm has a fifty day moving average price of $22.65 and a two-hundred day moving average price of $22.40. The firm has a market cap of $42.25 billion, a price-to-earnings ratio of 41.71, a P/E/G ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were given a $0.205 dividend. The ex-dividend date was Wednesday, February 12th. This represents a $0.82 annualized dividend and a dividend yield of 3.71%. Kenvue’s dividend payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.